RVNC - Revance Therapeutics, Inc.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 3.4

Open

$ 3.25

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.25 - $ 3.54

52 Week Range

$ 3.21 - $ 37.98

Volume

2,280,332

Average Volume

Market Cap

287.64M

Beta (5Y Monthly)

$ 1.40

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-10-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	11-09-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	02-26-2020	12-31-2019	10-K
18	11-04-2019	09-30-2019	10-Q
19	08-06-2019	06-30-2019	10-Q
20	05-09-2019	03-31-2019	10-Q
21	02-28-2019	12-31-2018	10-K
22	11-02-2018	09-30-2018	10-Q
23	08-03-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	03-02-2018	12-31-2017	10-K
26	11-03-2017	09-30-2017	10-Q
27	08-04-2017	06-30-2017	10-Q
28	05-09-2017	03-31-2017	10-Q
29	02-28-2017	12-31-2016	10-K
30	11-04-2016	09-30-2016	10-Q
31	08-05-2016	06-30-2016	10-Q
32	05-10-2016	03-31-2016	10-Q
33	03-04-2016	12-31-2015	10-K
34	11-10-2015	09-30-2015	10-Q
35	08-07-2015	06-30-2015	10-Q
36	05-14-2015	03-31-2015	10-Q
37	03-04-2015	12-31-2014	10-K
38	11-13-2014	09-30-2014	10-Q
39	08-13-2014	06-30-2014	10-Q
40	05-14-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Revance To Present New DAXXIFY Data At The...
04/12/2024 12:01:57

– Two presentations highlighting data on DAXXIFY® for the treatment of cervical dystonia, including a new analysis from ASPEN t...

BlackBerry, Nurix Therapeutics, Tesla And ...
04/09/2024 14:43:45

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...

gds-holdings-coinbase-and-other-big-stocks-moving-higher-in-mondays-pre-market-session

GDS Holdings, Coinbase And Other Big Stock...
03/11/2024 09:50:45

U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdin...

why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Bitdeer Technologies Shares Are Tradin...
03/04/2024 18:29:18

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

Tesla, Spirit Airlines, New York Community...
03/04/2024 15:40:18

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

Revance Announces Pricing Of $100M Public ...
03/04/2024 14:26:45

Revance Therapeutics, Inc. (NASDAQ:RVNC) ("Revance" or the "Company") today announced the pricing of an underwr...

Revance Announces Proposed Public Offering...
03/04/2024 11:38:25

Goldman Sachs Maintains Neutral on Revance...
03/01/2024 11:04:25

Goldman Sachs analyst Chris Shibutani maintains Revance Therapeutics (NASDAQ:RVNC) with a Neutral and raises the price targe...

HC Wainwright & Co. Reiterates Buy on Reva...
02/29/2024 20:18:03

HC Wainwright & Co. analyst Douglas Tsao reiterates Revance Therapeutics (NASDAQ:RVNC) with a Buy and maintains $12 pric...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
02/29/2024 17:32:04

Hormel Foods Reports Upbeat Earnings, Join...
02/29/2024 16:30:35

U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.

Piper Sandler Maintains Overweight on Reva...
02/29/2024 13:43:26

Piper Sandler analyst David Amsellem maintains Revance Therapeutics (NASDAQ:RVNC) with a Overweight and lowers the price tar...

Needham Maintains Buy on Revance Therapeut...
02/29/2024 13:34:25

Needham analyst Serge Belanger maintains Revance Therapeutics (NASDAQ:RVNC) with a Buy and lowers the price target from $20 ...

Revance Expects 2024 Total Product Revenue...
02/28/2024 21:27:23

2024 Guidance and Financial Outlook•Product revenue guidance: Revance expects 2024 total product revenue, which includes sales ...

Revance Therapeutics Q4 EPS $(0.62) Beats ...
02/28/2024 21:26:07

Revance Therapeutics (NASDAQ:RVNC) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of ...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Earnings Outlook For Revance Therapeutics
02/27/2024 14:02:06

HC Wainwright & Co. Maintains Buy on Revan...
02/23/2024 14:32:54

HC Wainwright & Co. analyst Douglas Tsao maintains Revance Therapeutics (NASDAQ:RVNC) with a Buy and lowers the price ta...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
02/02/2024 13:06:01